BioTelemetry, Inc. Reports Fourth Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
CardioNet (BEAT) PT Raised to $41 at Dougherty & Co
February 23, 2018 8:19 AM ESTDougherty & Co raised its price target on CardioNet (NASDAQ: BEAT) to $41.00 (from $40.00) while maintaining a Buy rating following strong results.
... MoreBioTelemetry (BEAT) Tops Q4 EPS by 8c
February 22, 2018 4:13 PM ESTBioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.32, $0.08 better than the analyst estimate of $0.24. Revenue for the quarter came in at $91.7 million versus the consensus estimate of $88.3 million.
For earnings history and earnings-related data on BioTelemetry (BEAT) click here.
... More